[Two-year survivor in response to gemcitabine-based chemotherapy for advanced pancreatic cancer with multiple lung

Osamu Takeyama1, Yuji Usui

  • 1Dept. of Surgery, Kyoto Senbai Hospital.

Related Concept Videos